isoxazoles has been researched along with B-Cell Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baffert, F; Bird, L; Bradner, JE; Chapuy, B; Christie, AL; De Pover, A; Ebel, N; Eck, MJ; Erdmann, D; Evrot, E; Gaul, C; Hofmann, F; Kopp, N; Kung, AL; Lane, AA; Levine, RL; Marubayashi, S; McKeown, M; Murakami, M; Paranal, RM; Radimerski, T; Régnier, CH; Romanet, V; Sallan, SE; Tiedt, R; Toms, AV; van Bodegom, D; Vangrevelinghe, E; Weigert, O; Weinstock, DM; Yoda, A | 1 |
1 other study(ies) available for isoxazoles and B-Cell Leukemia
| Article | Year |
|---|---|
Genetic resistance to JAK2 enzymatic inhibitors is overcome by HSP90 inhibition.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; DNA Primers; Female; Flow Cytometry; Gene Expression Profiling; HSP90 Heat-Shock Proteins; Humans; Immunoblotting; Immunohistochemistry; Isoxazoles; Janus Kinase 2; Leukemia, B-Cell; Luciferases; Mice; Mice, Inbred BALB C; Mutagenesis; Mutation, Missense; Myeloproliferative Disorders; Phosphorylation; Receptors, Cytokine; Resorcinols; RNA, Small Interfering; Signal Transduction; X-Ray Microtomography | 2012 |